(Q35973882)

English

AIDS-related cancer in the era of highly active antiretroviral therapy (HAART): a model of the interplay of the immune system, virus, and cancer. "On the offensive--the Trojan Horse is being destroyed"--Part A: Kaposi's sarcoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

AIDS-related cancer in the era of highly active antiretroviral therapy (HAART): a model of the interplay of the immune system, virus, and cancer. "On the offensive--the Trojan Horse is being destroyed"--Part A: Kaposi's sarcoma (English)

1 reference

Europe PubMed Central

11 August 2017

anti-retroviral agent

0 references

author name string

Tony W Cheung

1

1 reference

Europe PubMed Central

11 August 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

11 August 2017

Cancer Investigation

1 reference

Europe PubMed Central

11 August 2017

22

1 reference

Europe PubMed Central

11 August 2017

774-786

1 reference

Europe PubMed Central

11 August 2017

5

1 reference

Europe PubMed Central

11 August 2017

KAPOSI'S SARCOMA IN HOMOSEXUAL MEN—A REPORT OF EIGHT CASES

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Kaposi's sarcoma and new herpesvirus

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Impaired CTL recognition of cells latently infected with Kaposi's sarcoma-associated herpes virus

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Evidence for multiclonality in multicentric Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Spectrum of AIDS-associated malignant disorders

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Clinical aspects and management of AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Immunologic abnormalities in homosexual men. Relationship to Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Antitumorigenic effects of HIV protease inhibitor ritonavir: inhibition of Kaposi sarcoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Highly active antiretroviral therapy does not protect against Kaposi's sarcoma in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

The impact of palliative irradiation on the management of patients with acquired immune deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Treatment of HIV-associated Kaposi's sarcoma with paclitaxel

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Mechanism of paclitaxel activity in Kaposi's sarcoma.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

The antiviral drug docosanol as a treatment for Kaposi's sarcoma lesions in HIV type 1-infected patients: a pilot clinical study

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Flavopiridol inhibits P-TEFb and blocks HIV-1 replication

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Activity of thalidomide in AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Monoclonality or Oligoclonality of Human Herpesvirus 8 Terminal Repeat Sequences in Kaposi's Sarcoma and Other Diseases

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200032788

21 January 2018

Identifiers

10.1081/CNV-200032788

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35973882&oldid=1609742048"